Skip to main content

Imperfect Agency and Non-Expected Utility Models

  • Chapter
  • First Online:
Medical Decision Making
  • 1139 Accesses

Abstract

The final chapter takes a more realistic stance to medical decision making by assuming that physicians are only imperfect agents of their patients. Specifically, we assume that physicians internalize only some share of the patient’s utility and follow a profit motive in their test and treatment decisions. We then analyze the effects of imperfect agency on the thresholds and discuss the role of liability rules and medical guidelines in regulating imperfect agency. Finally, we present non-expected utility models under risk and uncertainty (i.e., ambiguity). While these models can explain observed test and treatment decisions, they are not suitable for normative analyses aimed at providing guidance on medical decision making.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    In a letter to Milton Friedman, dated August 25, 1950, Paul Samuelson, an originally severe critic, wrote that he accepted the expected utility theory after Leonard Savage persuaded him of the normative force of the Independence Axiom (quoted after Moscati 2016).

  2. 2.

    Note that the parameter β can also capture potential moral hazard in the case of the patient whose medical costs are covered by health insurance coverage. Instead of paying the full price, this patient only pays a fraction \( 1-\beta \) of the treatment cost.

  3. 3.

    Note that these conditions were also required in Chap. 5 for the effect of an increase in the willingness to pay for a QALY on the test-treatment threshold being positive.

  4. 4.

    This explains the classification as rank-dependent choice model.

  5. 5.

    Note the similarity between the threshold analysis under the dual theory and the analysis of the certainty equivalent under EUT.

  6. 6.

    In the framework of non-EUT models, the value of information relates to differences in outcomes rather than differences in EUT.

  7. 7.

    Another interpretation is that these are weighting factors for the size of a trial in a meta-analysis of prevalence estimates.

References

  • Abdellaoui, M. (2000). Parameter-free elicitation of utility and probability weighting functions. Management Sciences, 46(11), 1497–1512.

    Article  Google Scholar 

  • Basinga, P., Moreira, J., Bisoffi, Z., Bisig, B., & Van den Ende, J. (2007). Why are clinicians reluctant to treat smear-negative tuberculosis? An inquiry about treatment thresholds in Rwanda. Medical Decision Making, 27, 53–60.

    Article  Google Scholar 

  • Berger, L., Bleichrodt, H., & Eeckhoudt, L. (2013). Treatment decisions under ambiguity. Journal of Health Economics, 32, 559–569.

    Article  Google Scholar 

  • Bleichrodt, H., & Pinto, J. L. (2000). A parameter-free elicitation of the probability weighting function in medical decision analysis. Management Sciences, 46(11), 1485–1496.

    Article  Google Scholar 

  • Danzon, P. M. (2000). Liability for medical malpractice. In A. J. Culyer & J. P. Newhouse, J. (Eds.), Handbook of health economics (1st ed., pp. 1339–1404). New York: Elsevier Science, North-Holland.

    Google Scholar 

  • DeKay, M. L., & Asch, D. A. (1998). Is the defensive use of diagnostic tests good for patients, or bad? Medical Decision Making, 18, 19–28.

    Article  Google Scholar 

  • Djulbegovic, B., Hozo, I., Beckstead, J., Tsalatsanis, A., & Pauker, S. G. (2012). Dual processing model of medical decision-making. BMC Medical Informatics and Decision Making, 12, 94.

    Article  Google Scholar 

  • Djulbegovic, B., van den Ende, J., Hamm, R. M., Mayrhofer, T., Hozo, I., & Pauker, S. (2015). When is rational to order a diagnostic test, or prescribe treatment: The threshold model as an explanation of practice variation. European Journal of Clinical Investigation, 45(5), 485–493.

    Article  Google Scholar 

  • Eeckhoudt, L. (2002). Risk and medical decision making. Boston: Kluwer.

    Book  Google Scholar 

  • Ellis, R. P., & McGuire, T. G. (1986). Provider behavior under prospective reimbursement. Journal of Health Economics, 5, 129–151.

    Article  Google Scholar 

  • Ellsberg, D. (1961). Risk, ambiguity, and the savage axioms. Quarterly Journal of Economics, 75(4), 643–669.

    Article  Google Scholar 

  • Hozo, I., & Djulbegovic, B. (2008). When is diagnostic testing inappropriate or irrational? Acceptable regret approach. Medical Decision Making, 28, 540–553.

    Article  Google Scholar 

  • Klibanoff, P., Marinacci, M., & Muerkji, S. (2005). A smooth model of decision making under ambiguity. Econometrica, 73(6), 1849–1892.

    Article  Google Scholar 

  • List, J. (2004). Neoclassical theory versus prospect theory: Evidence from the market place. Econometrica, 72(2), 615–625.

    Article  Google Scholar 

  • Loomes, G., & Sugden, R. (1982). Regret theory: An alternative theory of rational choice. Economic Journal, 92, 805–824.

    Google Scholar 

  • McGuire, T. G. (2000). Physician agency. In: A. J. Culyer & J. P. Newhouse, J. (Eds.), Handbook of health economics (1st ed., pp. 461–536). New York: Elsevier Science, North-Holland.

    Google Scholar 

  • Moscati, I. (2016). How economists came to accept expected utility theory: The case of Samuelson and Savage. The Journal of Economic Perspectives, 30(2), 219–236.

    Article  Google Scholar 

  • Pauker, S. G., & Pauker, S. P. (1998). Expected utility perspectives on defensive testing: Torts, tradeoffs, and thresholds—Is defensive medicine defensible? Medical Decision Making, 18, 29–31.

    Article  Google Scholar 

  • Raiffa, H. (1968). Decision analysis: Introductory lectures on choices under uncertainty. Reading, MA: Addison-Wesley.

    Google Scholar 

  • Raiffa, H. (1961). Risk, uncertainty and the savage axioms: Comment. Quarterly Journal of Economics, 75, 690–694.

    Article  Google Scholar 

  • Savage, L. J. (1954). The foundations of statistics. New York: Wiley.

    Google Scholar 

  • Wakker, P. P. (2008). Lessons learned by (from?) an economist working in medical decision making. Medical Decision Making, 28(5), 690–698.

    Article  Google Scholar 

  • Wakker, P. P. (2010). Prospect theory: For risk and ambiguity. Cambridge: Cambridge University Press.

    Book  Google Scholar 

  • Yaari, Y. (1987). The dual theory of choice under risk. Econometrica, 55(1), 95–115.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Exercises

Exercises

  1. 1.

    Consider a lottery with the following outcomes: \( {h}_1=10;{h}_2=16;{h}_3=25 \) and the corresponding probabilities \( {p}_1=0.1,{p}_2=0.5,{p}_3=0.4. \) The utility function is \( u(h)=h \) the probability weighting function is \( w(p)=\sqrt{p} \). What is the value of the lottery under EUT and under the dual theory framework, resp.?

  2. 2.

    Assume the following utility function \( u(h)=\sqrt{h} \) and the following probability weighting function \( w(p)=\sqrt{p} \). Moreover, let’s assume a patient with an a priori probability of illness equal to p = 0.2 and a diagnostic test with characteristics Se = Sp = 0.8. Outcomes (measured in life years) are as follows: \( {h}_s^{-}=9;{h}_s^{+}=16;{h}_h^{+}=25;{h}_h^{-}=36. \)

    1. (a)

      Draw the decision tree in extensive and normal forms (note that the outcomes should be ranked from lowest to highest)

    2. (b)

      What is the certainty equivalent, i.e., value attached to the decision (in life years) using the extensive form under

      1. (1)

        EUT

      2. (2)

        Yaari’s dual theory

    3. (c)

      What is the certainty equivalent (in life years) using the normal form under

      1. (1)

        EUT

      2. (2)

        Yaari’s dual theory

    4. (d)

      Compare the results of (b) and (c) and discuss.

  3. 3.

    Let’s assume two physicians, one is ambiguity neutral and acts according to EUT with \( u(h)=\sqrt{h} \) and one is ambiguity averse with the same (elementary) utility function but also \( \varphi (EU)=\sqrt{EU} \). Moreover, both physicians see the same patient. Health outcomes are as follows \( {h}_s^{-}=4;{h}_s^{+}=16;{h}_h^{+}=25;{h}_h^{-}=36. \)

    1. (a)

      Assume that the a priori probability of illness for that patient is 30 %.

      1. (1)

        Calculate \( E{U}^{+} \) and \( E{U}^{-} \) for the first physician. What will he do?

      2. (2)

        Calculate \( {V}^{+} \) and \( {V}^{-} \) for the second physician. What will he do?

    2. (b)

      Assume now that the a priori probability of illness is uncertain and can take two values, p 1 and p 2 with \( {p}_1=10\% \) and \( {p}_2=50\% \). Furthermore, \( \mu =50\% \) denotes the subjective probability of both physicians that p 1 is the true probability of illness and \( 1-\mu =50\% \) denotes the subjective probability with which both physicians believe that p 2 is the true a priori probability of illness (note that the weighted expected a priori probability of illness is the same as before: \( \overline{p}=\mu {p}_1+\left(1-\mu \right){p}_2=30\% \)).

      1. (1)

        Calculate \( E{U}^{+} \) and \( E{U}^{-} \) for the first physician. What will he do?

      2. (2)

        Calculate \( {V}^{+} \) and \( {V}^{-} \) for the second physician. What will he do?

      3. (3)

        Compare the results of (a) and (b) and discuss observed behavior vs. “what should a physician do”?

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Germany

About this chapter

Cite this chapter

Felder, S., Mayrhofer, T. (2017). Imperfect Agency and Non-Expected Utility Models. In: Medical Decision Making. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53432-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53432-8_11

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53431-1

  • Online ISBN: 978-3-662-53432-8

  • eBook Packages: Economics and FinanceEconomics and Finance (R0)

Publish with us

Policies and ethics